Bayer Aktiengesellschaft (BIT:1BAYN)

Italy flag Italy · Delayed Price · Currency is EUR
33.61
+0.11 (0.33%)
At close: Dec 5, 2025
73.70%
Market Cap 32.72B
Revenue (ttm) 45.87B
Net Income (ttm) -198.00M
Shares Out n/a
EPS (ttm) -0.20
PE Ratio n/a
Forward PE 7.01
Dividend 0.11 (0.33%)
Ex-Dividend Date Apr 28, 2025
Volume 30,361
Average Volume 76,320
Open 33.66
Previous Close 33.50
Day's Range 33.24 - 33.91
52-Week Range 18.44 - 35.04
Beta 0.83
RSI 72.27
Earnings Date Nov 12, 2025

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft operates as a life science company worldwide. The company operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skin... [Read more]

Sector Healthcare
Founded 1863
Employees 91,864
Stock Exchange Borsa Italiana
Ticker Symbol 1BAYN
Full Company Profile

Financial Performance

In 2024, Bayer Aktiengesellschaft's revenue was 46.61 billion, a decrease of -2.16% compared to the previous year's 47.64 billion. Losses were -2.55 billion, -13.23% less than in 2023.

Financial Statements

News

There is no news available yet.